Table 3.
Anticipation effect in families with BRCA1/2 mutations after controlling for ascertainment bias
Breast Cancer, probands excluded
(N=447) |
Ovarian Cancer, probands excluded (N=67) | |||||||
---|---|---|---|---|---|---|---|---|
Generation | N |
Mean
AoO † |
Δ AoO (95% CI) | P-value | N |
Mean
AoO † |
Δ AoO (95% CI) | P-value |
Grandparents’ gen | 81 | 51.5 | 10.5 (6.6, 14.3) | <0.001 | 14 | 56.9 | 8.6 (1.7, 15.5) | 0.014 |
Parents’ gen | 189 | 48.0 | 7.0 (4.2, 9.7) | <0.001 | 32 | 52.7 | 4.4 (−1.0, 9.8) | 0.11 |
Probands’ gen | 146 | 41.0 | 0 (ref) | 19 | 48.3 | 0 (ref) | ||
Children’s gen | 31 | 35.0 | −6.0 (−10.7, 1.3) | 0.013 | 2 | 37.9 | −10.4 (−24.2, 3.3) | 0.14 |
mutation probability-weighted age of onset in years
Abbreviations: Δ AoO, difference in years of age of onset; CI, confidence intervals; gen, generation; ref, reference.